Antiretroviral Activity Of a Novel Pyrimidyl-Di(Diazaspiroalkane) Derivative.

A novel compound, 3,3'-(5-nitropyrimidine-4,6-diyl)bis-3,12-diaza-6,9-diazoniadispiro[5.2.5.2]hexadecane tetrachloride dihydrochloride, was synthesized. The compound was found to inhibit the replication of various viral families by blocking specific heparan sulfate receptors on the host cell's surface. In experiments, the compound was found to be highly effective against several strains of HIV retroviruses.

Identification of individual structural fragments of N,N'-(bis-5-nitropyrimidyl)dispirotripiperazine derivatives for cytotoxicity and antiherpetic activity allows the prediction of new highly active compounds.

OBJECTIVES: The objectives of this study were (i) to apply computer-based technologies to evaluate the structure of 48 N,N'-(bis-5-nitropyrimidyl)dispirotripiperazines which belong to a new class of highly active antiviral compounds binding to cell surface heparan sulphates, (ii) to understand the chemical- biological interactions governing their activities, and (iii) to design new compounds with strong antiviral activity. METHODS: The logarithm of 50% cytotoxic concentration (CC(50)) in GMK cells, of 50% inhibitory concentration (IC(50)) against herpes simplex virus type 1, and of selectivity index (SI = CC(50)/IC(50)) was used to develop quantitative structure-activity relationships (QSARs) based on simplex representation of molecular structure. The QSAR model was applied to design new compounds. Two of these compounds were synthesized, physico-chemically characterized and tested for cytotoxicity and antiviral activity. RESULTS: Statistic characteristics for partial least squares models allow the prediction of CC(50), IC(50) and SI values. The QSAR results demonstrate a high impact of individual structural fragments for antiviral activity. Molecular fragments that promote and interfere with antiviral activity were defined on the basis of the obtained models. Electrostatic factors (38%) and hydrophobicity (34%) were the most important determinants of antiherpetic activity. Using the established method, new potential dispirotripiperazine derivatives were computationally designed. Two of these computationally designed compounds were synthesized. The biological test results confirm the computationally predicted values of these compounds. CONCLUSIONS: The established QSAR model is suitable for the design of new antiherpetic compounds and prediction of their activity.

[Modern methods for formaldehyde, methanol and ethanol analysis].

It is necessary to create very specific and sensitive methods for assaying formaldehyde and methanol which are produced on the large scale and are very toxic and have mutagenic and carcinogenic action on living organisms. The methods for determination of formaldehyde, methanol and ethanol in the environment and fermentation products published and developed by the authors are reviewed in this paper. Most of the known methods are not sufficiently selective and sensitive and some of them are very expensive. Classical chemical, enzymatic, chemosensor and biosensor approaches used for methanol and formaldehyde assay are described. Enzymatic methods exploiting alcohol oxidase isolated from the mutant over-producing strain of methylotrophic yeast Hansenula polymorpha permit efficient determination of formaldehyde in industrial wastewaters. Enzymatic-chemical method based on the use of alcohol oxidase and 4-amino-5-hydrazine-3-mercapto-1,2,4-triazole (AHMT) allows simultaneous determination of methanol and formaldehyde. The technology of biosensor construction and their bioanalytical characteristics are described. Experimental data concerning amperometric and potentiometric biosensors based on the use of genetically modified cells of methylotrophic yeast Hansenula polymorpha are reviewed. The possibility to use alcohol oxidase-based biosensor for the assay of methanol in wastewater is demonstrated.

[Antiulcer activity of furoxanopyrimidine derivatives]. / Protivoiazvennoe deistvie proizvodnykh furoksapirimidina.

A series of four new furoxanopyrimidine derivatives was synthesized and studied with respect to antiulcerous, antisecretory, and antibacterial activity. Two compounds exhibit antiulcerous effect not accompanied (in contrast to the well-known H2 receptor blockers, quiditene, and other antiulcerous drugs) by inhibition of gastric acid secretion. No one of the studied compounds exhibited antibacterial activity in the tests with Helicobacter pylori.